Analysis of Patient Outcomes following Platelet Rich Plasma Treatmentfor Joint Osteoarthritis
- Conditions
- OsteoarthiritisMusculoskeletal painMusculoskeletal - OsteoarthritisMusculoskeletal - Other muscular and skeletal disorders
- Registration Number
- ACTRN12620000802909
- Lead Sponsor
- Surecell Medical Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 1078
•Were 18 years and over of age.
•They received PRP treatment for pain and/or loss of function due to knee OA.
•They received PRP treatment for pain and/or loss of function due to pes anserine bursitis.
•They received PRP treatment for pain and/or loss of function due to ankle osteoarthritis.
•They received PRP treatment for pain and/or loss of function due to an anterior talofibular ligament sprain.
•They received PRP treatment for pain and/or loss of function due to an anterior talofibular ligament tear.
•Were under 18 years of age.
•Were immuno-compromised.
•Had a current malignancy.
•Had a current or recent joint infection.
•Had taken non-steroidal anti-inflammatory drugs 2 days before treatment or corticosteroids during the three weeks before treatment.
•Were pregnant or breastfeeding.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain, assessed by the visual analogue scale consists of an 11 point scale with 0 being 'no pain at all' and 10 being ‘worst imaginable pain.’ [Baseline (before PRP injection) and within 2-3 months following the participant’s final PRP treatment. The date of the final PRP treatment was noted for each participant and was used as a guide to determine when the 2-3 month follow up would happen. ]
- Secondary Outcome Measures
Name Time Method Pain was the main outcome measure, no secondary measures [None]